NCT06527885 - Lurasidone Non-Interventional Study in Schizophrenia Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 21, 2022

Primary Completion Date

September 12, 2023

Study Completion Date

September 12, 2023

Conditions

Schizophrenia

Interventions

DRUG

Lurasidone

Patients treated with Lurasidone in according to routine clinical practice, in Italy

Trial Locations (3)

Azienda Sanitaria Azienda ospedaliero-universitaria Senese, Siena

ASST degli Spedali Civili di Brescia, Brescia

Villa Von Siebenthal, Genzano di Roma